Literature DB >> 27829687

Network abnormalities and interneuron dysfunction in Alzheimer disease.

Jorge J Palop1,2, Lennart Mucke1,2.   

Abstract

The function of neural circuits and networks can be controlled, in part, by modulating the synchrony of their components' activities. Network hypersynchrony and altered oscillatory rhythmic activity may contribute to cognitive abnormalities in Alzheimer disease (AD). In this condition, network activities that support cognition are altered decades before clinical disease onset, and these alterations predict future pathology and brain atrophy. Although the precise causes and pathophysiological consequences of these network alterations remain to be defined, interneuron dysfunction and network abnormalities have emerged as potential mechanisms of cognitive dysfunction in AD and related disorders. Here, we explore the concept that modulating these mechanisms may help to improve brain function in these conditions.

Entities:  

Mesh:

Year:  2016        PMID: 27829687     DOI: 10.1038/nrn.2016.141

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  258 in total

1.  Simultaneous EEG and fMRI of the alpha rhythm.

Authors:  Robin I Goldman; John M Stern; Jerome Engel; Mark S Cohen
Journal:  Neuroreport       Date:  2002-12-20       Impact factor: 1.837

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

4.  Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

Authors:  Julie A Harris; Nino Devidze; Laure Verret; Kaitlyn Ho; Brian Halabisky; Myo T Thwin; Daniel Kim; Patricia Hamto; Iris Lo; Gui-Qiu Yu; Jorge J Palop; Eliezer Masliah; Lennart Mucke
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

5.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

6.  Stimulus specificity of phase-locked and non-phase-locked 40 Hz visual responses in human.

Authors:  C Tallon-Baudry; O Bertrand; C Delpuech; J Pernier
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

7.  Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo.

Authors:  Thomas Klausberger; Peter J Magill; László F Márton; J David B Roberts; Philip M Cobden; György Buzsáki; Peter Somogyi
Journal:  Nature       Date:  2003-02-20       Impact factor: 49.962

8.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

9.  Increased cortical and thalamic excitability in freely moving APPswe/PS1dE9 mice modeling epileptic activity associated with Alzheimer's disease.

Authors:  Kestutis Gurevicius; Arto Lipponen; Heikki Tanila
Journal:  Cereb Cortex       Date:  2012-05-10       Impact factor: 5.357

10.  Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory.

Authors:  Anna G Orr; Edward C Hsiao; Max M Wang; Kaitlyn Ho; Daniel H Kim; Xin Wang; Weikun Guo; Jing Kang; Gui-Qiu Yu; Anthony Adame; Nino Devidze; Dena B Dubal; Eliezer Masliah; Bruce R Conklin; Lennart Mucke
Journal:  Nat Neurosci       Date:  2015-01-26       Impact factor: 24.884

View more
  246 in total

1.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

2.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

3.  Quantum-like behavior without quantum physics II. A quantum-like model of neural network dynamics.

Authors:  S A Selesnick; Gualtiero Piccinini
Journal:  J Biol Phys       Date:  2018-06-08       Impact factor: 1.365

4.  Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer's Disease Pathology.

Authors:  Milan Stoiljkovic; Craig Kelley; Bernardo Stutz; Tamas L Horvath; Mihály Hajós
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

Review 5.  Circadian regulation of membrane physiology in neural oscillators throughout the brain.

Authors:  Jodi R Paul; Jennifer A Davis; Lacy K Goode; Bryan K Becker; Allison Fusilier; Aidan Meador-Woodruff; Karen L Gamble
Journal:  Eur J Neurosci       Date:  2019-01-29       Impact factor: 3.386

6.  Synaptic Adhesion Molecule Pcdh-γC5 Mediates Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Yanfang Li; Zhicai Chen; Yue Gao; Gaojie Pan; Honghua Zheng; Yunwu Zhang; Huaxi Xu; Guojun Bu; Hui Zheng
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

7.  Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline.

Authors:  Kamalini G Ranasinghe; Jungho Cha; Leonardo Iaccarino; Leighton B Hinkley; Alexander J Beagle; Julie Pham; William J Jagust; Bruce L Miller; Katherine P Rankin; Gil D Rabinovici; Keith A Vossel; Srikantan S Nagarajan
Journal:  Sci Transl Med       Date:  2020-03-11       Impact factor: 17.956

8.  Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer's Disease.

Authors:  Magdalena Martinez-Losa; Tara E Tracy; Keran Ma; Laure Verret; Alexandra Clemente-Perez; Abdullah S Khan; Inma Cobos; Kaitlyn Ho; Li Gan; Lennart Mucke; Manuel Alvarez-Dolado; Jorge J Palop
Journal:  Neuron       Date:  2018-03-15       Impact factor: 17.173

9.  Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.

Authors:  Willem Huijbers; Aaron P Schultz; Kathryn V Papp; Molly R LaPoint; Bernard Hanseeuw; Jasmeer P Chhatwal; Trey Hedden; Keith A Johnson; Reisa A Sperling
Journal:  J Neurosci       Date:  2018-11-27       Impact factor: 6.167

10.  Pathological missorting of endogenous MAPT/Tau in neurons caused by failure of protein degradation systems.

Authors:  Varun Balaji; Senthilvelrajan Kaniyappan; Eckhard Mandelkow; Yipeng Wang; Eva-Maria Mandelkow
Journal:  Autophagy       Date:  2018-09-13       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.